DataMeds AI (MEDS) Revenue (2024 - 2026)

DataMeds AI (MEDS) has reported Revenue for 3 consecutive years, with $1.6 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Revenue fell 85.64% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $14.0 million (down 51.59% YoY), and the FY2025 full-year result was $23.3 million, up 28.73% from the prior year.
• Revenue fell to $1.6 million in Q1 2026 per MEDS's latest filing, from $1.7 million in the prior quarter.
• Across five years, Revenue topped out at $12.4 million in Q4 2024 and bottomed at $44540.0 in Q2 2024.
• Historically, Revenue has averaged $5.4 million across 3 years, with a median of $4.3 million in 2024.
• The widest YoY moves for Revenue: up 17391.84% in 2025, down 86.54% in 2025.
• Over 3 years, Revenue stood at $12.4 million in 2024, then tumbled by 86.54% to $1.7 million in 2025, then declined by 6.65% to $1.6 million in 2026.
• According to Business Quant data, Revenue over the past three periods registered $1.6 million, $1.7 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.